-- 
Al-Khodari Sons, Gulf Pharmaceutical, Sanad: Gulf Equity Preview

-- B y   M o u r a d   H a r o u t u n i a n
-- 
2011-08-21T02:00:00Z

-- http://www.bloomberg.com/news/2011-08-21/al-khodari-sons-gulf-pharmaceutical-sanad-gulf-equity-preview.html
The following stocks may rise or
fall in Persian Gulf markets. Stock symbols are in parentheses
and prices are from the last close.  Saudi Arabia’s  Tadawul All Share Index (SASEIDX)  fell the most in two
weeks, losing 2.6 percent to 5,931.29. Dubai’s  DFM General Index (DFMGI) 
climbed less than 0.1 percent, while  Abu Dhabi ’s  ADX General
Index (ADSMI)  slid less than 0.1 percent.  Abdullah A.M. Al-Khodari Sons Co. (ALKHODAR)  : The Saudi
Arabian contracting company signed a contract valued at 24
million riyals ($6.4 million) with the Ministry of Municipal and
Rural Affairs to develop a cleaning project in Skaka city. The
shares dropped 1.6 percent to 62.75 riyals.  Gulf Pharmaceutical Industries (JULPHAR UH): The United
Arab Emirates-based medical drugs and supplies producer known as
Julphar plans to build a $26 million factory in Algeria. The
shares were unchanged at 2.15 dirhams.  Sanad Cooperative Insurance & Reinsurance Co. (SANAD)  :
The Saudi Arabian insurer named Philip William Head as its new
chief executive officer. The shares slumped 3.4 percent to 14.15
riyals.  To contact the reporter on this story:
Mourad Haroutunian in Riyadh at 
 mharoutunian@bloomberg.net   To contact the editor responsible for this story:
Shaji Mathew at 
 shajimathew@bloomberg.net  